Wu, Yixiao
Bissinger, Thomas
Genzel, Yvonne
Liu, Xuping
Reichl, Udo
Tan, Wen-Song
Funding for this research was provided by:
China Scholarship Council
Article History
Received: 30 June 2020
Revised: 1 December 2020
Accepted: 9 December 2020
First Online: 30 January 2021
Change Date: 12 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00253-021-11286-y
Compliance with ethical standards
:
: Wen-Song Tan and Xuping Liu are affiliated as directors with Shanghai BioEngine Sci-Tech and were involved in the development of the Xeno-CDM medium both for scientific and commercial purposes. The remaining authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable
: Not applicable
: Not applicable
Free to read: This content has been made available to all.